Baker Brothers Advisors - AEGERION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$6,027,000
-17.1%
9,517,0000.0%0.04%
-27.4%
Q1 2018$7,273,000
-3.9%
9,517,0000.0%0.06%
-6.1%
Q4 2017$7,566,000
-0.1%
9,517,0000.0%0.07%
+8.2%
Q3 2017$7,576,000
-34.4%
9,517,000
-34.4%
0.06%
-39.6%
Q2 2017$11,549,000
-12.8%
14,517,000
-12.1%
0.10%
-6.5%
Q1 2017$13,241,000
-30.7%
16,517,000
-37.7%
0.11%
-42.2%
Q4 2016$19,103,000
+9.6%
26,517,0000.0%0.19%
+18.4%
Q3 2016$17,432,000
+17.5%
26,517,0000.0%0.16%
+1.3%
Q2 2016$14,840,000
+9.7%
26,517,0000.0%0.16%
+9.1%
Q1 2016$13,526,000
-22.9%
26,517,0000.0%0.14%
-1.4%
Q4 2015$17,552,000
-11.7%
26,517,0000.0%0.14%
-21.2%
Q3 2015$19,873,00026,517,0000.18%
Other shareholders

There were no reported owners of AEGERION PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of AEGERION PHARMACEUTICALS INC shareholders